TNF-receptor-1 adaptor protein FAN mediates TNF-induced B16 melanoma motility and invasion

British Journal of Cancer

Volumn 109, Issue 2, 2013, Pages 422-432

  Boecke, A ^a   Carstens, A C ^a   Neacsu, C D ^a   Baschuk, N ^a,c   Haubert, D ^a,b   Kashkar, H ^a   Utermohlen O ^a   Pongratz, C ^a   Kronke M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

cellular motility; matrix degradation; TNF signalling; tumour invasion

Indexed keywords

ADAPTOR PROTEIN; FAN PROTEIN; METALLOPROTEINASE; PAXILLIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; IN VITRO STUDY; MELANOMA B16; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TUMOR INVASION; ZEBRA FISH;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; FEMALE; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84881098475     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.242     Document Type: Article

References (45)

1. Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J, Krönke M (1996) FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86: 937-947.
2. Adam D, Wiegmann K, Adam-Klages S, Ruff A, Krönke M (1996) A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. J Biol Chem 271: 14617-14622.
3. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC (2006) Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: Defining the stages of invadopodia formation and function. Cancer Res 66: 3034-3043.
4. Badowski C, Pawlak G, Grichine A, Chabadel A, Oddou C, Jurdic P, Pfaff M, Albiges-Rizo C, Block MR (2008) Paxillin phosphorylation controls invadopodia/podosomes spatiotemporal organization. Mol Biol Cell 19: 633-645.
5. Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9: 361-371.
6. Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7: 211-217.
7. Bauvois B (2004) Transmembrane proteases in cell growth and invasion: New contributors to angiogenesis? Oncogene 23: 317-329.
8. Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J Pathol 196: 254-265.
9. Boecke A, Sieger D, Neacsu CD, Kashkar H, Krönke M (2012) Factor associated with neutral sphingomyelinase activity mediates navigational capacity of leukocytes responding to wounds and infection: Live imaging studies in zebrafish larvae. J Immunol 189: 1559-1566.
10. Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC (1999) An invasionrelated complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 18: 4440-4449.
11. Brown MC, Turner CE (2004) Paxillin: Adapting to change. Physiol Rev 84: 1315-1339.
12. Cervero P, Himmel M, Krüger M, Linder S (2012) Proteomic analysis of podosome fractions from macrophages reveals similarities to spreading initiation centres. Eur J Cell Biol 91: 908-922.
13. Chang C, Werb Z (2001) The many faces of metalloproteases: Cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11: S37-S43.
14. Clark EA, Golub TR, Lander ES, Hynes RO (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406: 532-535.
15. Condeelis J, Pollard JW (2006) Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 124: 263-266.
16. Dekker SK, Vink J, Vermeer BJ, Bruijn JA, Mihm Jr. MC, Byers HR (1994) Differential effects of interleukin 1-alpha (IL-1 alpha) or tumor necrosis factor-alpha (TNF-alpha) on motility of human melanoma cell lines on fibronectin. J Invest Dermatol 102: 898-905.
17. Fuortes M, Jin WW, Nathan C (1994) Beta 2 integrin-dependent tyrosine phosphorylation of paxillin in human neutrophils treated with tumor necrosis factor. J Cell Biol 127: 1477-1483.
18. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: The next generation. Cell 144: 646-674.
19. Hanna AN, Berthiaume LG, Kikuchi Y, Begg D, Bourgoin S, Brindley DN (2001) Tumor necrosis factor-alpha induces stress fiber formation through ceramide production: Role of sphingosine kinase. Mol Biol Cell 12: 3618-3630.
20. Haubert D, Gharib N, Rivero F, Wiegmann K, Hösel M, Krönke M, Kashkar H (2007) PtdIns(4,5)P-restricted plasma membrane localization of FAN is involved in TNF-induced actin reorganization. EMBO J 26: 3308-3321.
21. Hou CH, Yang RS, Hou SM, Tang CH (2010) TNF-alpha increases alphavbeta3 integrin expression and migration in human chondrosarcoma cells. J Cell Physiol 226: 792-799.
22. Kreder D, Krut O, Adam-Klages S, Wiegmann K, Scherer G, Plitz T, Jensen JM, Proksch E, Steinmann J, Pfeffer K, Krönke M (1999) Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. EMBO J 18: 2472-2479.
23. Lai FP, Szczodrak M, Block J, Faix J, Breitsprecher D, Mannherz HG, Stradal TE, Dunn GA, Small JV, Rottner K (2008) Arp2/3 complex interactions and actin network turnover in lamellipodia. EMBO J 27: 982-992.
24. Leber TM, Balkwill FR (1998) Regulation of monocyte MMP-9 production by TNF-alpha and a tumour-derived soluble factor (MMPSF). Br J Cancer 78: 724-732.
25. Linder S (2007) The matrix corroded: Podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol 17: 107-117.
26. Linder S, Aepfelbacher M (2003) Podosomes: Adhesion hot-spots of invasive cells. Trends Cell Biol 13: 376-385.
27. Montfort A, de Badts B, Douin-Echinard V, Martin PG, Iacovoni J, Nevoit C, Therville N, Garcia V, Bertrand MA, Bessieres MH, Trombe MC, Levade T, Benoist H, Segui B (2009) FAN stimulates TNF(alpha)-induced gene expression, leukocyte recruitment, and humoral response. J Immunol 183: 5369-5378.
28. Mueller SC, Chen WT (1991) Cellular invasion into matrix beads: Localization of beta 1 integrins and fibronectin to the invadopodia. J Cell Sci 99(Pt 2): 213-225.
29. Murphy DA, Courtneidge SA (2011) The 'ins' and 'outs' of podosomes and invadopodia: Characteristics, formation and function. Nat Rev Mol Cell Biol 12: 413-426.
30. Nakahara H, Howard L, Thompson EW, Sato H, Seiki M, Yeh Y, Chen WT (1997) Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA 94: 7959-7964.
31. Peppelenbosch M, Boone E, Jones GE, van Deventer SJ, Haegeman G, Fiers W, Grooten J, Ridley AJ (1999) Multiple signal transduction pathways regulate TNF-induced actin reorganization in macrophages: Inhibition of Cdc42-mediated filopodium formation by TNF. J Immunol 162: 837-845.
32. Petit V, Boyer B, Lentz D, Turner CE, Thiery JP, Valles AM (2000) Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells. J Cell Biol 148: 957-970.
33. Philipp S, Puchert M, Adam-Klages S, Tchikov V, Winoto-Morbach S, Mathieu S, Deerberg A, Kolker L, Marchesini N, Kabelitz D, Hannun YA, Schutze S, Adam D (2010) The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase. Proc Natl Acad Sci USA 107: 1112-1117.
34. Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4: 71-78.
35. Pongratz C, Yazdanpanah B, Kashkar H, Lehmann MJ, Krausslich HG, Krönke M (2010) Selection of potent non-toxic inhibitory sequences from a randomized HIV-1 specific lentiviral short hairpin RNA library. PLoS One 5: E13172.
36. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR (2003) Cell migration: Integrating signals from front to back. Science 302: 1704-1709.
37. Rosen EM, Goldberg ID, Liu D, Setter E, Donovan MA, Bhargava M, Reiss M, Kacinski BM (1991) Tumor necrosis factor stimulates epithelial tumor cell motility. Cancer Res 51: 5315-5321.
38. Tcherkasowa AE, Adam-Klages S, Kruse ML, Wiegmann K, Mathieu S, Kolanus W, Krönke M, Adam D (2002) Interaction with factor associated with neutral sphingomyelinase activation, a WD motifcontaining protein, identifies receptor for activated C-kinase 1 as a novel component of the signaling pathways of the p55 TNF receptor J Immunol 169: 5161-5170.
39. Tsubouchi A, Sakakura J, Yagi R, Mazaki Y, Schaefer E, Yano H, Sabe H (2002) Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and migration. J Cell Biol 159: 673-683.
40. Wilson NS, Dixit V, Ashkenazi A (2009) Death receptor signal transducers: Nodes of coordination in immune signaling networks. Nat Immunol 10: 348-355.
41. Wolf K, Friedl P (2009) Mapping proteolytic cancer cell-extracellular matrix interfaces. Clin Exp Metastasis 26: 289-298.
42. Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DA, Glennie MJ, Kelland LR, Robinson V, Stratford IJ, Tozer GM, Watson S, Wedge SR, Eccles SA (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102: 1555-1577.
43. Yamaguchi H, Condeelis J (2007) Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 1773: 642-652.
44. Yamaguchi H, Pixley F, Condeelis J (2006) Invadopodia and podosomes in tumor invasion. Eur J Cell Biol 85: 213-218.
45. Zhu N, Lalla R, Eves P, Brown TL, King A, Kemp EH, Haycock JW, MacNeil S (2004) Melanoma cell migration is upregulated by tumour necrosis factor-alpha and suppressed by alpha-melanocyte-stimulating hormone. Br J Cancer 90: 1457-1463.